Forschungszentrum für Immuntherapie (FZI)
Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz
Heidler, Felicita; Bopp, Tobias; Schwab, Matthias et al.
Infections and multiple sclerosisFORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE. 2024
Pape, Katrin; Vogts, Lea; Schraad, Muriel et al.
Influence of dimethyl fumarate on immunosenescence signatures in multiple sclerosisMULTIPLE SCLEROSIS JOURNAL. Bd. 30. H. 3. 2024 S. 1225-1225
Neerukonda, Manjusha; Curella, Valentina; Sielaff, Malte et al.
INFLUENCE OF PROCESSING OF WHEAT FLOURS ON THEIR PROINFLAMMATORY TLR4-ACTIVATING POTENTIAL BY ATISGASTROENTEROLOGY. Bd. 166. H. 5. 2024 S. S738-S739
Dhillon-LaBrooy, Ayesha; Braband, Kathrin L.; Tantawy, Eshraq et al.
Inhibition of Mitochondrial Translation Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation by Targeting Vy4D y8 T CellsJOURNAL OF INVESTIGATIVE DERMATOLOGY. Bd. 144. H. 4. 2024
Liu, Hao; Xing, Fei; Yu, Peiyun et al.
Integrated design and application of stimuli-responsive metal-organic frameworks in biomedicine: current status and future perspectivesJOURNAL OF MATERIALS CHEMISTRY B. Bd. 12. H. 34. 2024 S. 8235-8266
Noriega, Alejandro Ceron; Kerber, Anne Julia Sarah; Sys, Stanislav et al.
Integrating Nanopore Sequencing: Unveiling High Dimensional Chromatin Dynamics through Epigenetic AssaysEUROPEAN JOURNAL OF HUMAN GENETICS. Bd. 32. 2024 S. 1657-1657
Herhaus, Lina; Gestal-Mato, Uxia; Eapen, Vinay V. et al.
IRGQ-mediated autophagy in MHC class I quality control promotes tumor immune evasionCELL. Bd. 187. H. 25. 2024
Leypoldt, Lisa B.; Tichy, Diana; Besemer, Britta et al.
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple MyelomaJOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 1. 2024 S. 26-+
Eich, Christina; Vogt, Johannes F.; Laengst, Vivian et al.
Isolation and high-dimensional flow cytometric analysis of tumor-infiltrating leukocytes in a mouse model of colorectal cancerFRONTIERS IN IMMUNOLOGY. Bd. 15. 2024
Bumma, Naresh; Richter, Joshua; Jagannath, Sundar et al.
Linvoseltamab for Treatment of Relapsed/Refractory Multiple MyelomaJOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 22. 2024